Fiche publication
Date publication
septembre 2024
Journal
Clinical colorectal cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BEN ABDELGHANI Meher
,
Pr GHIRINGHELLI François
Tous les auteurs :
Assaf I, Bregni G, Anthoine G, Aparicio T, Artru P, Abdelghani MB, Buyse M, Chibaudel B, Coart E, Diaz M, Evrard C, Geboes K, Ghiringhelli F, Puleo F, Raimbourg J, Vandamme T, Van den Eynde M, Hendlisz A, Sclafani F
Lien Pubmed
Résumé
Evidence suggests that ctDNA may be a reliable biomarker to monitor metastatic colorectal cancer (CRC) evolution. Nevertheless, evidence on the potential of liquid biopsy in this setting is still low quality, mostly consisting of retrospective studies.
Mots clés
Circulating tumour DNA, Early treatment switch, Early tumour response assessment
Référence
Clin Colorectal Cancer. 2024 09 3;:
